BioSpace News Archive

An international gathering of biological engineers, cell biologists, and affiliated scientists will discuss breakthroughs in optogenetics research, and how these technologies are translating to real-world applications, including healthcare, industry, and other areas, at the 3rd Optogenetic Technologies and Applications Conference, to be held December 1–3, 2022, at the Heidelberg Marriott Hotel in Heidelberg, Germany.

electroCore, Inc. announced today that gammaCore Sapphire™, the first and only FDA cleared non-invasive device to treat and prevent multiple types of headache pain via the vagus nerve, will be distributed and billed exclusively by Joerns Healthcare, LLC (Joerns) within select managed care health systems.

The Canadian labelling for all Janus Kinase inhibitors is being updated to include the risks of serious heart-related problems, fatal blood clots and cancer.

Proscia®, a leading provider of digital and computational pathology solutions, has released study results on new artificial intelligence (AI) that predicts diagnostic agreement for melanoma, the deadliest form of skin cancer.

Captario is pleased to announce that Sobi®, one of the largest Swedish biopharmaceutical companies developing and providing sustainable access to innovative medicines for the treatment of rare diseases, has stepped ahead of their peers’ digital journey by choosing to partner with Captario in their efforts to increase efficiency in their strategic drug development initiatives.

Captario, the life science SaaS-platform decision analytics company, announces the launch of Professional Services to further enable strategic decision-making throughout the drug development process.

Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on November 1, 2022 that were approved by the Compensation Committee of its Board of Directors under Company’s 2022 Inducement Equity Incentive Plan, as a material inducement to employment to 3 individuals hired by Acutus in September 2022.

Inspire Medical Systems, Inc. reported financial results for the quarter ended September 30, 2022.

Emergent BioSolutions Inc. (NYSE:EBS) announced results from a Phase 2 study evaluating the safety and immunogenicity of the company’s adjuvanted single dose chikungunya virus virus-like particle (CHIKV VLP) vaccine candidate in prior recipients of other investigational alphavirus vaccines.

Cocrystal Pharma, Inc. (Nasdaq: COCP) announces it has been granted European patent EP3866778 titled “Combinations Of Inhibitors of Influenza Virus Replication,” which covers the Company’s broad-spectrum oral PB2 inhibitor CC-42344 in combination with approved influenza antiviral drugs including Tamiflu®, Xofluza® or Favipiravir.